|
⚲
|
| Keyboard |
| Temeng Kwaku
✚
|
|
|---|---|
| CIK # | 0001846675 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001846675] | |
| 4 | [0001846675] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Temeng Kwaku | |
| Core Laboratories Inc /DE/ | |
| Core Laboratories N V |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Core Laboratories Inc /DE/ CLB
Common Stock
|
2025-04-01 | Option exercise | 9,317 | $0.00 | |
|
Core Laboratories Inc /DE/ CLB
Restricted Shares · derivative
|
2025-04-01 | Grant | 8,069 | $0.00 | |
|
Core Laboratories Inc /DE/ CLB
Restricted Shares · derivative
|
2025-04-01 | Option exercise | 9,317 | $0.00 | |
|
Core Laboratories Inc /DE/ CLB
Common Stock
|
2024-04-01 | Option exercise | 6,419 | $0.00 | |
|
Core Laboratories Inc /DE/ CLB
Restricted Shares · derivative
|
2024-04-01 | Grant | 9,317 | $0.00 | |
|
Core Laboratories Inc /DE/ CLB
Restricted Shares · derivative
|
2024-04-01 | Option exercise | 6,419 | $0.00 | |
|
Core Laboratories N V CLB
Restricted Shares · derivative
|
2023-04-01 | Option exercise | 5,485 | $0.00 | |
|
Core Laboratories N V CLB
Common Shares
|
2023-04-01 | Option exercise | 5,485 | $0.00 | |
|
Core Laboratories N V CLB
Restricted Shares · derivative
|
2023-04-01 | Grant | 6,419 | $0.00 | |
|
Core Laboratories N V CLB
Restricted Shares · derivative
|
2022-04-01 | Grant | 5,485 | $0.00 | |
|
Core Laboratories N V CLB
Common Shares
|
2022-04-01 | Option exercise | 4,307 | $0.00 | |
|
Core Laboratories N V CLB
Restricted Shares · derivative
|
2022-04-01 | Option exercise | 4,307 | $0.00 | |
|
Core Laboratories N V CLB
Restricted Shares · derivative
|
2021-05-19 | Grant | 4,307 | $0.00 |